Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis

NCT00142051 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

18

Enrollment

OTHER

Sponsor class

Stopped 18 or 20 enrolled, stopped due to paucity of available participants

Conditions

Sickle Cell Disease

Interventions

DRUG: nitric oxide
DRUG: oxygen

Sponsor

Boston Children's Hospital

Collaborators

[object Object]